The recently FDA-approved BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid, a PCR-based diagnostic tool, can detect 11 different pathogens simultaneously from stool specimens of patients showing signs and/or symptoms of gastrointestinal infection. Compatible with bioMérieux's BIOFIRE® FILMARRAY® 2.0 and Torch PCR systems, this test requires a minimal setup time of 2 minutes and delivers results in approximately 1 hour.
This innovative panel enhances bioMérieux's BIOFIRE® GI portfolio. It represents a modified version of the current comprehensive BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel, which identifies 22 pathogens and has been available since 2014, offering laboratories efficient processing with rapid, detailed results that enhance diagnostic accuracy and patient care outcomes.
BIOFIRE® Gastrointestinal (GI) Panel Mid will be released for commercial use in the United States by mid-2025.
Click here to read the full press release.
